Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum toxin injection vs nasal fluticasone spray in allergic rhinitis
IRCT201506079014N67Phase 2Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Jun 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2 trial of neuronox and fluticasone in allergic rhinitis (AR) (2 arms), sponsored by Hamadan University of Medical Sciences. Started Jun 2015; status: completed.
02
Drugs
neuronoxfluticasone
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on IRCT201506079014N67.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201506079014N67.